Snowball logo
logo
LIMN

Liminatus Pharma, Inc. Class A Common Stock

LIMN NASDAQ
$0.1856+$0.0058  (3.23%)

Frequently asked questions

What sector does Liminatus Pharma, Inc. Class A Common Stock (LIMN) operate in?

Liminatus Pharma, Inc. Class A Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) current stock price?

As of the latest data, Liminatus Pharma, Inc. Class A Common Stock stock price is $0.19, with a previous close of $0.18. Liminatus Pharma, Inc. Class A Common Stock gained $0.01 in the last trading session, representing a 3.23% increase.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) current market capitalization?

Liminatus Pharma, Inc. Class A Common Stock market cap is approximately 8.33 million.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings Per Share (EPS)?

The trailing EPS is -$0.43.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) EBITDA?

Liminatus Pharma, Inc. Class A Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.15 million.

Does Liminatus Pharma, Inc. Class A Common Stock (LIMN) pay dividends?

No. Liminatus Pharma, Inc. Class A Common Stock does not pay a dividend.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) beta (volatility) score?

Liminatus Pharma, Inc. Class A Common Stock has a beta of 0.628, indicating lower volatility than the overall market.